ArticleCancer cell international2023

Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells.

Phatchanat Klaihmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.